Orac Deco Extra

Hazard statements (CLP)

H315, H317, H319, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

Hazard statements

Carc. category 2 H351: Suspected of causing cancer. STOT RE category 2 H373: May cause damage to organs through prolonged or repeated exposure if inhaled. Eye Irrit. category 2 H319: Causes serious eye irritation. STOT SE category 3 H335: May cause respiratory irritation. Skin Irrit. category 2 H315: Causes skin irritation. Resp. Sens. category 1 H334: May cause allergy or asthma symptoms or breathing culties if inhaled. Skin Sens. category 1 H317: May cause an allergic skin reaction. 2.1.2 Classi cation according to Directive 67/548/EEC-1999/45/EC Classi ed as dangerous in accordance with the criteria of Directives 67/548/EEC and 1999/45/EC Carc. Cat. 3; R40 - Limited evidence of a carcinogenic ect Xn; R48/20 - Harmful: danger of serious damage to health by prolonged exposure through inhalation. Xi; R36/37/38 - Irritating to eyes, respiratory system and skin. R42/43 - May cause sensitisation by inhalation and skin contact. H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure if inhaled. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H315 Causes skin irritation. H334 May cause allergy or asthma symptoms or breathing difculties if inhaled. H317 May cause an allergic skin reaction.

2.2 Label elements

Reason for revision: CLP Created by: Brandweerinformatiecentrum voor gevaarlijke sto en vzw (BIG) Publication date 2003-01-30 134-15960-371-en Technische Schoolstraat 43 A, B-2440 Geel Date of revision 2012-11-18 Date of revision 2013-07-01 http://www.big.be © BIG vzw Labelling

Contains

4,4'-methylenediphenyl diisocyanate 4,4'-methylenediphenyl diisocyanate

Precautionary statements

P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P280 Wear protective gloves and eye protection/face protection. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P261 Avoid breathing. P309 + P311 IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician. P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P501 Dispose of contents/container to manufacturer/competent authority.

Additional information

Persons already sensitised to diisocyanates may develop allergic reactions when using this product. - Persons sufering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. - This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas flter (i.e. type A1 according to standard EN 14387) is used. Labelling according to Directive 67/548/EEC-1999/45/EC (DSD/DPD) Labels Harmful

R-phrase(s)

36/37/38 Irritating to eyes, respiratory system and skin 40 Limited evidence of a carcinogenic efect 42/43 May cause sensitisation by inhalation and skin contact 48/20 Harmful: danger of serious damage to health by prolonged exposure through inhalation

S-phrase(s)

02) (Keep out of the reach of children) 23 Do not breathe vapour 36/37 Wear suitable protective clothing and gloves 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible) (63) (In case of accident by inhalation: remove casualty to fresh air and keep at rest) Additional recommendations Contains isocyanates. See information supplied by the manufacturer. - Persons already sensitised to diisocyanates may develop allergic reactions when using this product. - Persons sufering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. - This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas flter (i.e. type A1 according to standard EN 14387) is used.

2.3 Other hazards

CLP No other hazards known DSD/DPD No other hazards known Reason for revision: CLP Publication date 2003-01-30 Date of revision 2013-07-01 Date of revision 2012-11-18